Nuo Therapeutics, Inc. (AURX) Executive Compensation
Nuo Therapeutics, Inc. (AURX) is a publicly traded company on the OTC, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AURX
CIK: 1091596
Exchange: OTC
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MaloneBailey, LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerSteven Vertucci
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-10-06 | FORM 4 - SCOTT PITTMAN - SECOND FUNDING WARRANTS | 0001437749-26-032249 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-09-30 | FORM 8-K | 0001437749-26-032242 | View SEC Doc Filr Page |
| 4/A | 2026-08-31 | 2026-08-27 | FORM 4/A | 0001437749-26-029257 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-27 | FORM 4 | 0001437749-26-029236 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-17 | FORM 8-K | 0001437749-26-028109 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001437749-26-028053 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-29 | FORM 4 | 0001437749-26-022670 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-29 | FORM 4 | 0001437749-26-022665 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-29 | FORM 4 | 0001437749-26-022664 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-29 | FORM 4 | 0001437749-26-022662 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-29 | FORM 4 | 0001437749-26-022661 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-05 | FORM 4 | 0001437749-26-019768 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-03 | — | SCHEDULE 13D/A Filing | 0001674752-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-05-29 | FORM 8-K | 0001437749-26-019199 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-05-29 | FORM 4 | 0001437749-26-019246 | View SEC Doc Filr Page |
| 4/A | 2026-06-02 | 2026-01-23 | FORM 4/A | 0001437749-26-019244 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | FORM 8-K | 0001437749-26-017116 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | FORM 10-Q | 0001437749-26-017104 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | FORM 10-K | 0001437749-26-010360 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-12 | — | SCHEDULE 13G/A Filing | 0001437749-26-003953 | View SEC Doc Filr Page |
| 4 | 2026-01-26 | 2026-01-23 | FORM 4 | 0001437749-26-002128 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-01-26 | — | SCHEDULE 13D/A Filing | 0001437749-26-002120 | View SEC Doc Filr Page |
| 8-K | 2026-01-26 | 2026-01-21 | FORM 8-K | 0001437749-26-002078 | View SEC Doc Filr Page |
| 4 | 2026-01-05 | 2026-01-01 | FORM 4 | 0001437749-26-000431 | View SEC Doc Filr Page |
| 4 | 2025-12-22 | 2025-12-17 | FORM 4 | 0001437749-25-038506 | View SEC Doc Filr Page |